VivGrant

Viva Biotech is a leading China-based CRO/CDMO providing one-stop services from early-stage structure-based drug R&D to commercial manufacturing. The company supports global pharmaceutical and biotech innovators with expertise in protein expression, purification, structure determination, hit screening, antibody discovery/production/humanization/maturation, medicinal chemistry (hit-to-lead/lead optimization), custom synthesis, ADME/PK studies, CMC development via its subsidiary Langhua Pharma. It has recently launched an AI-driven drug discovery platform and expanded operations into the US. The company operates under an equity-for-service model with some startups and has over 2,000 employees worldwide.